Neurology Minute

Latest Episodes:

Sports, Exercise, and Seizure Control - Part 1 Aug 07, 2023

Show notes

In part 1 of a 2-part series, Dr. Halley Alexander explores the potential benefits and risks involved for individuals with epilepsy who desire to actively engage in sports or exercise activities.

A Round Table Update Discussion on FND: Diagnosis of FND and New Phenotypes Aug 04, 2023

Show notes

Dr. David Perez discusses the diagnosis of FND and new phenotypes.

This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

AAN President Elect Rost to Testify on New Alzheimer's Treatments Aug 03, 2023

Show notes

Dr. Natalia Rost discusses her testimony to Congress on New Alzheimer's Treatments.

Show references:

This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

When Myoclonus is Reversible Aug 02, 2023

Show notes

Dr. Kathryn Zuchowski discusses her NeuroByte, "When Myoclonus Is Reversible".

Show references: https://learning.aan.com/diweb/catalog/item?id=11546015

This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

2024 Medicare Physician Fee Schedule Proposed Rule Aug 01, 2023

Show notes

Matt Kershner, Director, of Regulatory Affairs & Policy, at the American Academy of Neurology, discusses the 2024 Medicare Physician Fee Schedule Proposed Rule.

Show references: https://www.aan.com/advocacy/capitol-hill-report

This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

Pediatric Epilepsy Surgery Jul 31, 2023

Show notes

Dr. Adam Hartman discusses pediatric epilepsy surgery.

Show references: https://www.thelancet.com/pdfs/journals/lanchi/PIIS2352-4642(23)00082-2.pdf

https://pubmed.ncbi.nlm.nih.gov/37212692/

This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

Elamipretide for Mytochondrial Myopathy Jul 28, 2023

Show notes

Dr. Amel Karaa discusses the use of elamipretide in participants with genetically confirmed primary mitochondrial myopathies.

Show references: https://n.neurology.org/content/101/3/e238

Sarepta Announces FDA Approval of ELEVIDYS Jul 27, 2023

Show notes

Dr. Hoda Abdel-Hamid discusses the recent FDA approval for the first-ever gene therapy for Duchenne muscular dystrophy.

Anti-Seizure Medication Jul 26, 2023

Show notes

Dr. Irfan Sheikh sheds light on the usage of anti-seizure medications within the inpatient setting.

Cognitive Decline Following Heart Attack Jul 25, 2023

Show notes

Dr. Rae Bacharach discusses the Neurology Today article, "Cognitive Decline Appears to Speed Up in the Years Following a Heart Attack".

Show references: https://journals.lww.com/neurotodayonline/fulltext/2023/07060/cognitive_decline_appears_to_speed_up_in_the_years.8.aspx

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected